ePOSTER LISTING
EPIDEMIOLOGY OF MS
The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia
Main Author: Seraj Makkawi, Jeddah, Saudi Arabia
Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study
Main Author: Saloua Mrabet, Mannouba, Tunisia
Impact of Gender on Multiple Sclerosis Natural History: Findings from a Tunisian Cohort
Main Author: Saloua Mrabet, Mannouba, Tunisia
Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS
Main Author: Nahid Beladi Moghadam, Tehran, Iran
Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman
Main Author: Salma Al-Abri, Muscat, Oman
Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience
Main Author: Ahmed Essmat, Cairo, Egypt
Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco.
Main Author: Rachid Lotfi, Béni Mellal, Morocco
Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden
Main Author: Meritxell Sabidó Espin, Darmstadt, Germany
Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region
Main Author: Murad Al-Naqshbandi, Dubai, United Arab Emirates
Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia.
Main Author: Awad Al Harbi, Riyadh, Saudi Arabia
A Nationwide Pharmaco Epidemiological Study of Multiple Sclerosis in Greece
Main Author: Christos Bakirtzis, Thessaloniki, Greece
Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province , Iran.
Main Author: Roshanak Mehdipour Dastjerdi, Isfahan, Iran
Familial MS in the South Caspian Sea
Main Author: Seyedmohammad Baghbanian, Sari, Iran
Challenges of MS Patients for Receiving Health Care Services
Main Author: Sharareh Eskandarieh, Tehran, Iran
Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East
Main Author: Samar Farouk Ahmed, Kuwait City, Kuwait
COVID-19 Vaccination in People with Multiple Sclerosis the Kuwait Experience
Main Author: Samar Farouk Ahmed, Kuwait City, Kuwait
Multiple Sclerosis During Pregnancy: Data from the MS Clinic in Benghazi Medical Center
Main Author: Anwaar Mukhtar Bennour, Benghazi, Libya
Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review
Main Author: Hayder K Hassoun, Annajaf Al ashraf, Iraq
Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study
Main Author: Sharareh Eskandarieh, Tehran, Iran
Prevalence of MS in Tehran, Iran in 2020 and Its Forecast for the Next 10 Years
Main Author: Sharareh Eskandarieh, Tehran, Iran
IMMUNOLOGY OF MS
Evaluation of Anti-JVC Antibody Index Evolution in Patients with Multiple Sclerosis
Main Author: Saloua Mrabet, Mannouba, Tunisia
First Study in Iraq About (HLA)-Drb1 * 15:01 as a Genetic Risk Factor for MS Initiation
Main Author: Alaa Hassan Khaliel, Baghdad, Iraq
The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID19 Vaccine
Main Author: Mehran Ghaffari, Tehran, Iran
MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay
Main Author: Alaa Elmazny, Manama, Bahrain
Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
Main Author: Nahad Sedaghat, Isfahan, Iran
Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
Main Author: Celia Oreja-Guevara, Madrid, Spain
COVID-19 in Multiple Sclerosis Patients in Dubai: Observational Study
Main Author: Mona Thakre, Dubai, United Arab Emirates
The Role of Gut Microbiata in Multiple Sclerosis
Main Author: Caesar Zahka, Dubai, United Arab Emirates
Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients
Main Author: Ahmed Dahshan, Cairo, Egypt
MRI IN MS
MRI Findings in Late-Onset Multiple Sclerosis; a Systematic Review and Meta-Analysis
Main Author: Amirreza Naseri, Tabriz, Iran
MS DIAGNOSIS
Adrenoleukodystrophy in Adults: About a Case
Main Author: Si Ahmed Hakim, Tizi Ouzou, Algeria
Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis
Main Author: Saloua Mrabet, Mannouba, Tunisia
Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients
Main Author: Celia Oreja-Guevara, Madrid, Spain
Psychotic Symptoms Revealing Multiple Sclerosis: Case Report
Main Author: Sondes Bader, Gabes, Tunisia
A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report
Main Author: Sara Ali Alshamali, Dubai, United Arab Emirates
Radiologically Isolated Syndrome Conversion to Multiple Sclerosis
Main Author: Fatemeh Sabeti, Isfahan, Iran
Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Main Author: Hayder K.Hassoun, Annajaf, Iraq
MS PATHOLOGY
Depression in Multiple Sclerosis
Main Author: Sondes Bader, Gabes, Tunisia
Anxiety in Patients with Multiple Sclerosis
Main Author: Sondes Bader, Gabes, Tunisia
Sleep Disorders in Multiple Sclerosis Patients
Main Author: Sondes Bader, Gabes, Tunisia
Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History
Main Author: Razieh Mofateh, Ahvaz, Iran
Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis
Main Author: Razieh Mofateh, Ahvaz, Iran
Does Multiple Sclerosis Change Lower Limbs Inter-Segmental Coordination During Walking?
Main Author: Razieh Mofateh, Ahvaz, Iran
Association of Multiple Sclerosis and COVID-19 Infection: A Case Report
Main Author: Ismail Ibrahim Ismail, Kuwait city, Kuwait
NEUROMYELITIS OPTICA
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography
Main Author: Nevin Shalaby, Cairo, Egypt
Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population
Main Author: Kediha Mohamed Islam, Algiers, Algeria
A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder
Main Author: Roshanak Mehdipour, Isfahan, Iran
The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran.
Main Author: Roshanak Mehdipour Dastjerdi, Isfahan, Iran
NMOSD: How Long to Treat
Main Author: Rajarshi Chakraborty, Lucknow, India
PEDIATRIC MS
Lennox-Gastaut Syndrome and MS: Is it a Coincidence?
Main Author: Lilia Megherbi, Tizi Ouzou, Algeria
Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut
Main Author: Georges Saab, Toronto, Canada
RECENT ADVANCES IN MS THERAPY
The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia
Main Author: Seraj Makkawi, Jeddah, Saudi Arabia
Neurofilament Light Chains: A Reliable Biomarker of Disease Activity in MS
Main Author: Ayesha Ashfaq, lahore, Pakistan
Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis
Main Author: Rasha Alderbi, Jeddah, Saudi Arabia
Real-World Experience with Cladribine in the MSBase Registry
Main Author: Helmut Butzkueven, Melbourne, Australia
Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients
Main Author: Asmaa Eissa, Cairo, Egypt
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
Main Author: Bassem I Yamout, Beirut, Lebanon
Multiple Sclerosis Specialized Nurses in Saudi Arabia: Challenge, and Opportunities
Main Author: Rola Alarieh, Riyadh, Saudi Arabia
Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS
Main Author: Alessandra Solari, Milan, Italy
Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone
Main Author: Kholoud M. Al-Otaibi, Jeddah, Saudi Arabia
Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab
Main Author: Carrie M. Hersh, Las Vegas, United States
Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis
Main Author: John Foley, Salt Lake City, United States
Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait
Main Author: Raed Alroughani, Kuwait City, Kuwait
Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab
Main Author: Jacqueline Nicholas, Columbus, United States
The Effect of Rituximab on Mood Disorders in Multiple Sclerosis
Main Author: Maryam Poursadeghfard, Shiraz, Iran
Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience)
Main Author: Amr Abdelsalam Zaki, cairo, Egypt
Epidemiology of COVID-19 in Patients with MS: A Hospital-Based Registry
Main Author: Sharareh Eskandarieh, Tehran, Iran
Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab
Main Author: Bassem I. Yamout, Abu Dhabi, United Arab Emirates
Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study
Main Author: Gavin Giovannoni, London, United Kingdom
Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis
Main Author: Roya Abolfazli, Tehran, Iran
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region
Main Author: Jihad Inshasi, Dubai, United Arab Emirates